Based on the findings of a review of published data, a new generation of plant based therapies are being developed with the aim of using plants to treat a wide range of ailments and diseases.
The work is being carried out by scientists from Oxford University, the University of Edinburgh and the University and the Medical Research Council (MRC).
These new drugs are being tested in animal models, using plant material such as hemp, bamboo, cotton, and rice.
“It is now clear that many diseases and conditions can be successfully treated with plant based therapeutics, but the technology is limited,” says Dr David Green, lead author of the new review, which was published in the journal Science.
“We are at a point where the most promising plant based drugs are able to treat some of the most common conditions.
It is now time to put the best of the latest scientific research to work and find new drugs to help us cure the most difficult conditions.”
What are plant based medicinal plants?
A plant based drug is a plant that has been grown in a controlled environment with no added chemicals, pesticides or herbicides.
This means that its ingredients are safe to use without harming the environment.
They can also be easily grown on a large scale and there is no need to spray pesticides or chemicals on the plants.
The latest generation of plants have been developed using new technology that allows them to be grown at low temperatures, which is vital to the growth of plants.
This is particularly useful in developing new plants that are genetically engineered, because it means that they can grow with a wide variety of plant types, so they can be grown on much smaller scales.
It also allows plants to be more easily grown indoors, which allows for a more natural environment for them to grow in.
The scientists working with the Oxford team believe that they have identified a number of plants that can be used in the treatment of conditions including diabetes, arthritis, epilepsy, inflammatory bowel disease and cancer.
The team say they have developed three drugs, but are working to make more.
These new compounds can also reduce the symptoms of certain conditions such as depression, fibromyalgia, and other chronic pain conditions, and help treat pain associated with cancer.
One of the compounds, called LPS1, is shown to treat multiple sclerosis (MS) and the development of cancer.
Another is called ZO4, which can be converted into an anti-inflammatory agent and can help reduce inflammation in the body.
This could be especially helpful for cancer patients, who are often diagnosed with advanced cancer at a young age.
Another compound called ZP6 is shown in research to reduce the severity of psoriasis and is also used in people with Crohn’s disease.
The Oxford team have also developed a compound called NPH4, that is able to suppress growth of a number species of fungi.
The compounds have also been used in animal research, and could be used for the treatment and prevention of some cancers, and some types of arthritis.
“These compounds can be useful for a range of conditions, including diabetes and arthritis, and for people with severe conditions, like Crohns disease,” Dr Green said.
“For example, we have developed a new compound that can reduce the inflammation associated with the disease, which could be useful in people who have been diagnosed with Crohns disease, or for people who suffer from arthritis and other conditions.”
Our work is just beginning to get a foothold in this area, and we are currently looking at ways of using these compounds in clinical trials.
“What can I do with them?
The Oxford scientists believe that the use of these compounds could have a huge impact on the way people manage their illnesses and are looking to create medicines that can help prevent disease.”
A number of these new compounds are already available, and are already being tested, so there is a huge potential for these compounds to be used by millions of people worldwide,” Dr David said.
The researchers believe that these compounds will also be useful as treatments for other conditions, such as cancer, diabetes and obesity.”
While the use and application of these drugs will be much more difficult for the time being, our findings show that they could be very beneficial in the future,” Dr Gold said.
This new work is published in Nature Communications.
More stories from the Future